Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats. 
Home
Equities
LIPO
Chart

Lipella Pharmaceuticals Inc.

LIPO

Jan 1 1970 00:00:00
2.30
▼-0.4200▼-15.44%
2.77
2.80
2.26
2.72
2.40k
-4.12
-0.5583
5.86M
2.55M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-11-01
Form PRE 14A
ID: 0001753926-24-001795
2024-11-01
Form 8-K
ID: 0001753926-24-001793
2024-10-18
Form 8-K
ID: 0001753926-24-001716
2024-10-17
Form SC 13D/A
ID: 0001753926-24-001713
2024-10-17
Form SC 13D/A
ID: 0001753926-24-001712
2024-09-11
Form 8-K
ID: 0001753926-24-001565
2024-08-23
Form 8-K
ID: 0001753926-24-001473
2024-08-19
Form SC 13D/A
ID: 0001753926-24-001449
2024-08-15
Form D
ID: 0001753926-24-001445
2024-08-13
Form 10-Q
ID: 0001753926-24-001419

You might find these companies interesting

AMTI
Applied Molecular Transport Inc.
Pharmaceutical Preparations (2834)
FHTX
Foghorn Therapeutics Inc.
Pharmaceutical Preparations (2834)
HRTX
Heron Therapeutics, Inc. /De/
Pharmaceutical Preparations (2834)
MSLPQ
Musclepharm Corp
Pharmaceutical Preparations (2834)
RZLT
Rezolute, Inc.
Pharmaceutical Preparations (2834)
AKTX
Akari Therapeutics Plc
Pharmaceutical Preparations (2834)
ADXS
Ayala Pharmaceuticals, Inc.
Pharmaceutical Preparations (2834)
VIRI
Virios Therapeutics, Inc.
Pharmaceutical Preparations (2834)
BLPH
Bellerophon Therapeutics, Inc.
Pharmaceutical Preparations (2834)
KANT
Kineta, Inc./de
Pharmaceutical Preparations (2834)
TARO
Taro Pharmaceutical Industries Ltd
Pharmaceutical Preparations (2834)
TNGX
Tango Therapeutics, Inc.
Pharmaceutical Preparations (2834)
PHGE
Biomx Inc.
Biological Products, (No Diagnostic Substances) (2836)
NYMXF
Nymox Pharmaceutical Corp
In Vitro & In Vivo Diagnostic Substances (2835)